Are your heart cholesterol blood pressure anxiety allergy pain medications best for you?
Are they safe together?
Get these answers and more with DNAimpactRx!
For decades, healthcare providers have been making decisions about your medications and dosages based on general guidelines for everyone. But, medication decisions should be based on what’s best for YOU.
With DNAimpactRx, you’ll learn how your genes impact the way your body responds to specific medications. Our clinical experts will help you and your healthcare provider ensure your medications and doses are right for you.
0
for eligible members
4-6
weeks
for personalized results
Why is Pharmacogenomics (PGx) Important?
Prescription medications don’t work the same for everyone. Things like your age, body size, health conditions, other medications, diet and lifestyle all play a part. Your genes matter too – some of them play a role in how your body processes medications. If there are changes in one of these genes, your body might break down a medication too quickly, too slowly, or sometimes not at all.
To unlock this information, you will send a saliva sample to the lab where your DNA is checked for gene changes that can affect how medications work. With those results, your doctor can make informed choices about the medication or dose that is likely to work best for you.
of people have gene changes
that impact how their body reacts to medication1-3
of people are prescribed at least
one medication impacted by gene changes4
of negative effects, allergic reactions, or overdoses could be prevented by PGx testing5
How DNAimpactRx Works
Take an active role in your healthcare decisions!
-
Get Started Today!
It’s easy to enroll, provide informed consent, and create your profile.
-
Take the Test
Follow easy at-home instructions and return in pre-paid envelope.
-
Prepare for Your Results
Complete your profile online if you haven’t already done so and get notified when your results are ready.
-
Meet with Providers
Meet with our pharmacogenomic experts and your healthcare provider to review any medication recommendations.
-
Use Your Results!
Your PGx report and discussion tools are there to help you play an active role in getting the medications that work best for you—both now and in the future.
Get Started Today!
Take the Test
Prepare for Your Results
Meet with Providers
Use Your Results!
Prepare for Your Results
Personalized PGx Test Report
Sharing your results helps you and your healthcare provider(s) understand what’s best for your health
Full report of all genetic variations identified through DNA analysis.
Lab Report
DNAimpactRx Report
We present your results and the information learned about how you process medications and share it with you in a digital journey as well as a downloadable report.
Discussion Guide
Use this guide to help prompt the topics and questions you want to cover with your doctors as you discuss your PGx summary.
Informed Genomic Care
is part of our DNA
InformedDNA began as the first telehealth genetic counseling company in the US, making genomics-informed care more accessible to people nationwide and and enabling you to take an active role in your healthcare decisions. We know that every person is unique, especially when it comes to how you respond to prescription medications. And we believe that the care you receive should be informed by understanding your DNA.
DNAimpact for PGx is aimed at doing just that.
At InformedDNA we are committed to enabling convenient, painless at-home PGx testing that delivers personalized recommendations and insights both you and your healthcare providers can use to make fully-informed decisions about your care.
With a genomics-guided approach to medication management, we can say good-bye to guessing and hello to better health decisions.
FAQs
PGx testing looks at your genes to see how you might respond to certain medications. Because everyone processes medications in their own way, the results can help your doctor pick the medication and dose that’s most likely to work for you—reducing side effects and making treatment more effective. Think of it as a personalized guide for safer, smarter prescribing.
The program is offered as a part of your benefits, and it’s available to you at no extra cost.
When you register for the program, you will be asked to share which healthcare provider(s) you’d like involved in your care. From there, our genetics experts will team up with you and your provider(s) to keep you fully informed. Your provider(s) will be notified when you enroll and again once your testing is complete. They’ll also have access to all of your reports, so they can use that information to help guide medication choices and adjust doses if needed.
Privacy considerations are important. Your genetic information is sensitive and must be protected. We understand this and set your privacy and data protection as our number one priority. For more information on your rights and our responsibilities regarding your private health information, please read our Notice of Privacy and Data Security policies.
- 1 Van Driest SL, Shi Y, Bowton EA, et al. Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing. Clin Pharmacol Ther. 2014 Apr;95(4):423-31.
- 2 Hodel F, De Min MB, Thorball CW, et al. Prevalence of actionable pharmacogenetic variants and high-risk drug prescriptions: A Swiss hospital-based cohort study. Clin Transl Sci. 2024 Sep;17(9):e70009. doi: 10.1111/cts.70009. PMID: 39263940; PMCID: PMC11391267.
- 3 Bush WS, Crosslin DR, Owusu-Obeng A, et al. Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network. Clin Pharmacol Ther. 2016 Aug;100(2):160-9. doi: 10.1002/cpt.350. Epub 2016 Jun 1. PMID: 26857349; PMCID: PMC5010878.
- 4 Schildcrout JS, Denny JC, Bowton E, et al. Optimizing drug outcomes through pharmacogenetics: a case for preemptive genotyping. Clin Pharmacol Ther. 2012 Aug;92(2):235-42. doi: 10.1038/clpt.2012.66. Epub 2012 Jun 27. PMID: 22739144; PMCID: PMC3785311.
- 5 Bardolia C, Matos A, Amin NS, et al. Utilizing pharmacogenomics to reduce adverse medication events. American Journal of Biomedical Science & Research. 2020;11(3):258–6
